← FDA DRUG APPROVALS
FDA ANDA · ANDA218742
FLUTICASONE PROPIONATE ALLERGY RELIEF
fluticasone propionate
Sponsor: GLENMARK SPECLT
APPLICATION
ANDA218742
TYPE
ANDA
ORIGINAL APPROVAL
2026-03-16
LATEST ACTION
2026-03-16
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Over-the-counter
Products
FLUTICASONE PROPIONATEOver-the-counter
FLUTICASONE PROPIONATE 0.05MG/SPRAY · SPRAY, METERED · NASAL
Approval history
2026-03-16UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.